Let’s provoke thought, spark discussion, & keep pace with the technologies reshaping healthcare.
If digital innovation were a medicine, we'd still be in Phase 1.
We are far from the maximum tolerated dose and the therapeutic window is wide open. But it won't stay that way forever.
The Dose of Innovation explores the bold ideas, emerging technologies, and leadership shifts reshaping healthcare. Through articles, conversations, and practical frameworks, the series examines how AI, real-time data, and new models of care are redefining what's possible—and what those changes mean for the leaders shaping healthcare's future.
Healthcare's Digital Dawn has begun. The only question is how you will lead through it.
Healthcare is entering a new era. AI, real-time data, scientific advancement, and exponential technological adoption are reshaping every aspect of healthcare — from discovery and development to care delivery and patient engagement.
The pace of progress is unlike anything healthcare has experienced before. Yet despite the remarkable advances already underway, we're still only beginning to explore digital's full potential. We're still in Phase 1.
Healthcare's Digital Dawn isn't something to fear. It's an invitation to reimagine what's possible because the real opportunity belongs to the leaders ready to embrace it.
If you're feeling restless right now—good. It means you're paying attention.
When the pace of external change exceeds our ability to adapt, restlessness is a natural response. But the most effective leaders don't try to eliminate that feeling—they channel it.
Restlessness becomes the catalyst for curiosity, continuous learning, and growth.
The goal isn't to eliminate restlessness. It's to transform it into momentum.
Because leaders who remain curious today will be better prepared for tomorrow's Business Unusual.
The rules are changing. Strategies, capabilities, and innovation roadmaps that once remained relevant for years can now become outdated in months. Healthcare leaders can no longer rely on yesterday's assumptions to solve tomorrow's challenges.
Business Unusual isn't about abandoning what made healthcare successful. It's about embracing new ways of thinking, learning, and leading when certainty becomes increasingly rare and adaptability becomes a defining capability.
But mindset alone isn't enough. Lasting transformation depends on how innovation is introduced, adopted, and sustained.
Innovation alone doesn't create impact. Adoption does.
Like any potent therapy, innovation must be introduced with the right dose, at the right time, and in the right context. Technology may move at digital speed, but people adopt change at human speed.
Healthcare doesn't need more innovation for innovation's sake. It needs innovation that people trust, adopt, and champion.
That's where thoughtful leadership — and a practical playbook — make all the difference.
Recognizing Healthcare's Digital Dawn is only the beginning. Restlessness must become momentum. Business Unusual must become a new way of leading. Innovation must be translated into sustained adoption.
The Dose Escalation Playbook brings these ideas together in a practical framework for leaders navigating accelerated change. Built around four complementary strategies, it is designed to help leaders build capability, inspire confidence, and create the conditions for continuous innovation.
Because we're still in Phase 1 —and the leaders who build readiness today will help shape what healthcare becomes tomorrow.
FOUNDER, DOSE OF INNOVATION
Behind Dose of Innovation is Dr Alex Condoleon, a healthcare executive, innovator, and student of leadership in times of accelerated change.
Through articles, frameworks, the Frontier Series and Dose Response conversations, Alex explores the ideas, technologies, and leadership shifts reshaping healthcare—translating complexity into practical insights for leaders navigating Healthcare's Digital Dawn.
His work sits at the intersection of healthcare, technology, leadership, and human behavior, exploring what it takes to lead with curiosity, courage, and confidence in times of accelerated change.
Because we're still in Phase I.